These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 49644)

  • 1. Letter: Day-transfusion centre for thalassaemics.
    McIntosh N
    Lancet; 1975 Jul; 2(7923):42. PubMed ID: 49644
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of hepatitis C in transfusion dependent thalassaemics & haemophilics.
    Bhattacharya DK; Bhattacharjee S; De M; Lahiri P
    Indian J Med Res; 1991 Dec; 94():430-2. PubMed ID: 1774095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Day-transfusion centre for patients with thalassaemia major.
    Vance JC
    Lancet; 1975 Apr; 1(7913):967-8. PubMed ID: 48137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to hepatitis-C virus in multitransfused thalassaemics--Indian experience.
    Bhattacharya DK
    J Assoc Physicians India; 1994 Feb; 42(2):174. PubMed ID: 7532165
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of two types of leukocyte removal filters on transfusion dependent thalassaemics.
    Jamal R; Mazeni NR; Hussin H
    Malays J Pathol; 2000 Dec; 22(2):79-83. PubMed ID: 16329539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalassemia in the outpatient department of the Yangon Children's Hospital in Myanmar: cost analysis of the day-care-room services for thalassemia.
    Aung Myo Han ; Khin Ei Han ; Thein Thein Myint
    Southeast Asian J Trop Med Public Health; 1992 Jun; 23(2):273-7. PubMed ID: 1439981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.
    Chakrabarti S; Pradhan P; Roy A; Hira M; Bandyopadhyay G; Bhattacharya DK
    Indian J Public Health; 2006; 50(1):43-4. PubMed ID: 17193761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common transfusion-transmitted infectious agents among thalassaemic children in Bangladesh.
    Mollah AH; Nahar N; Siddique MA; Anwar KS; Hassan T; Azam MG
    J Health Popul Nutr; 2003 Mar; 21(1):67-71. PubMed ID: 12751676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a standard-of-care for transfusion therapy in thalassemia?
    Franchini M; Forni GL; Liumbruno GM
    Curr Opin Hematol; 2017 Nov; 24(6):558-564. PubMed ID: 28719386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in Transfusion Requirements Among Children With Thalassemia on Regular Transfusion Programs: Which Formula Closely Predicts the Actual Requirements?
    Cornell N; Eisenhut M; Ramprakash S
    J Pediatr Hematol Oncol; 2017 Oct; 39(7):e388-e390. PubMed ID: 28060132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequencies of hepatitis B, delta and human immune deficiency virus markers in multitransfused Saudi patients with thalassaemia and sickle-cell disease.
    el-Hazmi MA; Ramia S
    J Trop Med Hyg; 1989 Feb; 92(1):1-5. PubMed ID: 2918572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive transfusion therapy in thalassemia major.
    Beard ME; Necheles TF; Allen DM
    Pediatrics; 1967 Nov; 40(5):911-5. PubMed ID: 6075668
    [No Abstract]   [Full Text] [Related]  

  • 13. The Incidence Rate of Acute Transfusion Reactions in Thalassemia Patients Referred to the Shiraz Thalassemia Centre, Shiraz, Iran, Before and After the Establishment of the Hemovigilance System.
    Kasraian L; Karimi MH
    Hemoglobin; 2015; 39(4):274-80. PubMed ID: 26036919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fetal hemoglobin in the follow-up of homozygous beta-thalassemia in blood transfusion treatment].
    Ferrara M; Ponte G; Esposito L
    Pediatria (Napoli); 1980 Dec; 88(4):541-8. PubMed ID: 6170042
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood transfusion therapy in thalassemia major. Experience of a 5-year period of activity in the Center for Hemoglobinopathies of the Pediatric Clinic of Naples].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1978 Dec; 86(4):537-46. PubMed ID: 750970
    [No Abstract]   [Full Text] [Related]  

  • 16. [Data on statural growth and skeletal maturation in thalassemia major as related to blood transfusion therapy].
    Esposito L; Ferrara M; Durante A
    Pediatria (Napoli); 1976 Jun; 84(2):235-46. PubMed ID: 1018993
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood transfusion in thalassemia--the Jerusalem experience].
    Goldfarb AW; Stupp-DaCosta Y; Manny N; Rachmilewitz EA
    Harefuah; 1985 Nov; 109(10):265-8. PubMed ID: 4093039
    [No Abstract]   [Full Text] [Related]  

  • 18. [Post-transfusion multiple isoantibodies in a girl with thalassemia major].
    Centa A; Marchi AG
    Minerva Pediatr; 1968 Mar; 20(10):518-21. PubMed ID: 5739011
    [No Abstract]   [Full Text] [Related]  

  • 19. Earlier initiation of transfusional and iron chelation therapies in recently born children with transfusion-dependent thalassemia.
    Origa R; Tatti F; Zappu A; Leoni GB; Dessì C; Moi P; Morittu M; Orecchia V; Denotti AR; Pilia MP; Anni F; Perra M; Casini MR; Barella S
    Am J Hematol; 2017 Nov; 92(11):E627-E628. PubMed ID: 28741691
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum ferritin in the follow-up of homozygotic beta-thalassemia treated with blood transfusion and iron-chelating agents].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1981 Sep; 89(3):479-92. PubMed ID: 7346759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.